Oral graft-versus-host disease.

Area of Science:

• Hematology
• Immunology
• Oncology

Background:

• Allogeneic hematopoietic cell transplantation (HCT) is a curative therapy for hematologic malignancies.
• Graft-versus-host disease (GVHD) is a major dose-limiting complication after allo-HCT.
• Oral GVHD frequently occurs, causing significant morbidity and impacting patient well-being.

Purpose of the Study:

• To highlight the importance of recognizing and managing oral GVHD.
• To emphasize the role of early diagnosis and long-term follow-up in improving patient outcomes.

Main Methods:

• This section is not applicable for this abstract as it focuses on clinical significance rather than specific experimental methods.
• Clinical observation and patient management principles.

Main Results:

• Oral GVHD leads to pain, functional impairment, and reduced quality of life.
• Effective management of oral GVHD is crucial for overall patient care.

Conclusions:

• Oral GVHD is a common and impactful complication of allo-HCT.
• Prompt diagnosis, treatment, and ongoing monitoring of oral GVHD are essential for optimizing patient care and quality of life.